University News

The National Cancer Institute, part of the National Institutes of Health, has provided over $3 million in support of a University of California, Davis, project to develop nanotechnology capable of diagnosing cancer from drops of saliva and other biofluid samples. 

J. Sebastian Gomez-Diaz, seated, and Randy Carney pose in Gomez-Diaz's Applied Micro/Nano Electromagnetics Research Laboratory. (Photo courtesy of Randy Carney)

Link to the original article published by Matt Marcure can be found here.

Researchers at the University of California, Davis, want to even out the differences in size and composition of naturally derived extracellular vesicles, or EVs, to turn them into a scalable and reliable drug platform, not unlike industrially produced medication. 

Link to the original article published by Matt Marcure can be found here.

Extracellular vesicles, or EVs, are nanoparticles released by every known cell and relay important messages across the human body — but how they exactly function is not well understood. Professors at the University of California, Davis, seek to change that.

Link to the original article by Matt Murphy can be found here. 

Biomedical Engineering Assistant Professor Randy Carney has received the National Science Foundation Faculty Early Career Development, or NSF CAREER, Award.  

Randy was recently named as the recipient of the 2022 University of California’s Shu Chien Early Career Jury Award.

This annual UC-wide award is given to early career faculty who demonstrate outstanding scholarly achievement. It is awarded at the UC Systemwide Bioengineering Symposium held each summer and recognizes the winner of a lecturer competition.

Dr. Carney was named the UC Davis Environmental Health Sciences (EHS) Annual Research Scholar! 

"Every year the UC Davis Environmental Health Sciences Center recognizes an up-and-coming researcher who shows exceptional talent and promise in their field of study."

Read an interview with Prof. Carney here about what this means to the lab!

The lab is very excited to announce receipt of a generous grant from the NIH National Cancer Institute (NCI) to generate a SERS diagnostic platform for liquid biopsy of tumor-associated exosomes. We've already begun working hard on this exciting project.